TCT 427: Comparison of Clinical Outcomes Between Second Generation Zotarolimus- Versus Everolimus-Eluting Stents up to 10-Year Follow-up
Presenter:
We Recommend
Disclosures
Nothing to disclose
New at TCTMD? Register today!
Enter the email you used to register to reset your password.